Date and Time | Title | |
---|---|---|
Apr 22, 2022 7:00am - 1:00pm (Pacific) | Joe Test | |
Apr 27, 2022 7:10am - 7:50am (Pacific) | DUPIXENT: For Patients > 6 Years of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis Learn more about a treatment that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Sponsored by Regeneron and Sanofi
This is a NON-CE/CME Presentation
| |
Apr 27, 2022 8:00am - 9:34am (Arizona) | Session I: Atopic Dermatitis Updates 8:00 AM PT | Welcome 8:15 AM PT | Atopic Dermatitis: Course and Comorbidities Across the Lifespan 8:30 AM PT | The Topical AD Toolbox 8:45 AM PT | New Data on Biologics for Atopic Dermatitis 9:00 AM PT | The Evolving Landscape of Oral Systemic AD Therapies 9:15 AM PT | Interactive Panel Q&A Supported by an independent educational grant from AbbVie ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology | |
Apr 27, 2022 9:40am - 9:55am (Pacific) | NON CME/CE Oral Poster Presentations This is a NON-CE/CME Presentation | |
Apr 27, 2022 10:00am - 10:20am (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 27, 2022 10:20am - 11:10am (Arizona) | Session I Continued: Atopic Dermatitis Updates 10:20 AM PT | The Itch Factor 10:35 AM PT | AD Guidelines in Context 10:50 AM PT | Interactive Panel Q&A Supported by an independent educational grant from AbbVie ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology | |
Apr 27, 2022 11:10am - 12:25pm (Arizona) | Session II: Pediatric Pearls for Practice 11:10 AM PT | Introduction 11:15 AM PT | Quick Check: Advances in Pediatric Atopic Dermatitis 11:30 AM PT | Quick Check: Pediatric Acne Best Practices 11:45 AM PT | Psoriasis in Pediatric Patients 12:05 AM PT | Pediatric Rashes Supported by an independent educational grant from Ortho Dermatologics, a division of Bausch Health ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours are in the area of pharmacology. | |
Apr 27, 2022 12:25pm - 12:40pm (Pacific) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 27, 2022 12:40pm - 1:20pm (Pacific) | Challenging AD Expectations A new therapy option that challenges treatment goals for patients with Refractory, Moderate to Severe Atopic Dermatitis (AD) who are not adequately controlled with other systemic drug products, including Biologics, or when use of those therapies are inadvisable.
Sponsored by AbbVie
This is a NON-CE/CME Presentation
| |
Apr 27, 2022 1:25pm - 1:35pm (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 27, 2022 1:35pm - 2:35pm (Arizona) | Session II Continued: Pediatric Pearls for Practice 1:35 PM PT | Expert Insights in the Treatment of Warts & Molluscum Contagiosum 1:55 PM PT | Making Sense of Rare Genetic Dermatologic Disorders 2:15 PM PT | Interactive Panel Q&A Supported by an independent educational grant from Ortho Dermatologics, a division of Bausch Health ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
SESSION II For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours are in the area of pharmacology. | |
Apr 27, 2022 2:40pm - 3:40pm (Pacific) | Independent CME/CE Symposium: Exploring Emerging Topical Treatments in Psoriasis: Are You Up to Date? Sponsored by Arcutis | |
Apr 27, 2022 3:40pm - 3:50pm (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 27, 2022 3:50pm - 6:05pm (Arizona) | Session III: The Psoriasis Forum 3:50 PM PT | Introduction 3:55 PM PT | Psoriasis Pathophysiology 4:10 PM PT | The Topical Psoriasis Treatment Update 4:25 PM PT | New Updates for TNF Inhibitors 4:40 PM PT | Interactive Panel Q&A 5:00 PM PT | Stretch Break 5:10 PM PT | The New Scene in Targeted Oral Agents 5:25 PM PT | What's New for IL-17 Targeted Treatments? 5:40 PM PT | The IL-23 Update 5:55 PM PT | Interactive Panel Q&A Supported by an independent educational grant from Janssen Biotech Inc, administered by Janssen Scientific Affairs, LLC Supported by an independent educational grant from AbbVie Supported by an independent educational grant from Arcutis Biotherapeutics, Inc. ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.5 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.5 contact hours are in the area of pharmacology. | |
Apr 27, 2022 6:15pm - 6:50pm (Pacific) | Innovations In Dermatology Sponsored by Pfizer
This is a NON-CE/CME Presentation
| |
Apr 28, 2022 7:10am - 7:40am (Pacific) | Changing Impressions of Topical Therapy: DUOBRII Lotion DUOBRII Lotion is the first and only steroid/retinoid therapy allowing halobetasol and tazarotene to work together in an advanced once-daily application that’s designed to help moisturize. [1-3]
Ref: 1. DUOBRII Lotion [prescribing information]. Bridgewater, NJ: Bausch Health US, LLC. 2. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutics Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm. Accessed March 24, 2022. 3. Tanghetti EA, Stein Gold L, Del Roso JQ, Lin T, Angel A, Pillai R. Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology. J Dermatolog Treat. 2021 32(4): 391-398.
Sponsored by Ortho Dermatologics
This is a NON-CE/CME Presentation | |
Apr 28, 2022 8:00am - 8:30am (Pacific) | Keynote Speaker: When Worlds Collide: The Intersection of Medical and Aesthetic Dermatology This is a NON CME/CE Presentation | |
Apr 28, 2022 8:50am - 9:50am (Arizona) | Session IV: Medical Dermatology Potpourri I 8:00 AM PT | Introduction 8:55 AM PT | What's New in Acne 9:15 AM PT | What's New in Rosacea 9:35 AM PT | The Microbiome in Acne and Rosacea 9:55 AM PT | What's New in Hidradenitis Suppurativa 10:15 AM PT | Women's Dermatologic Concerns 10:35 AM PT | Interactive Panel Q&A 10:55 AM PT | Poster Presentations Supported by an independent educational grant from Ortho Dermatologics, a division of Bausch Health Supported by an independent educational grant from AbbVie ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 1.5 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology. | |
Apr 28, 2022 11:16am - 11:40am (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 28, 2022 11:40am - 1:07pm (Arizona) | Session V: Medical Dermatology Potpourri II 11:40 PM PT | Introduction 11:45 AM PT | Making the Most of Teledermatology 12:05 PM PT | Chronic Spontaneous Urticaria 12:25 PM PT | Advances in Alopecia Areata 12:45 PM PT | Interactive Panel Q&A ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.25 contact hours are in the area of pharmacology. | |
Apr 28, 2022 1:05pm - 1:25pm (Pacific) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 28, 2022 1:25pm - 1:50pm (Pacific) | Managing Plaque Psoriasis Across All Severities An Oral Therapy with Data in Difficult–to-Treat Areas. Sponsored by Amgen This is a NON-CE/CME Presentation | |
Apr 28, 2022 2:10pm - 2:35pm (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 28, 2022 2:35pm - 3:35pm (Arizona) | Session V Continued: Medical Dermatology Potpourri II 2:35 PM PT | Updates in Vitiligo 2:55 PM PT | Prurigo Nodularis 3:15 PM PT | Interactive Panel Q&A ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
SESSION V For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.25 contact hours are in the area of pharmacology. | |
Apr 28, 2022 3:45pm - 4:25pm (Arizona) | Session VI: Medical Dermatology Potpourri III 3:45 PM PT | Introduction 3:50 PM PT | It's the Pits: Optimizing Treatment of Hyperhidrosis 4:10 PM PT | Actinic Keratosis Insights ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 1.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.5 contact hours are in the area of pharmacology. | |
Apr 28, 2022 4:25pm - 4:55pm (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 28, 2022 4:55pm - 5:50pm (Arizona) | Session VI Continued: Medical Dermatology Potpourri III 4:55 PM PT | Supportive Oncodermatology: What the **** is That? 5:15 PM PT | Artificial Intelligence in Dermatology 5:35 PM PT | Interactive Panel Q&A
ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
| |
Apr 28, 2022 6:00pm - 6:30pm (Pacific) | Taltz: An Overview of Efficacy and Safety in Plaque Psoriasis and Psoriatic Arthritis This presentation includes a clinical overview of disease manifestations, clinical efficacy, and safety outputs from relevant pivotal trials. The facilitator will provide clinical insights and be available for a live Q&A session following the presentation. Sponsored by Lilly This is a NON-CE/CME Presentation | |
Apr 29, 2022 8:00am - 9:20am (Arizona) | Session VII: Aesthetics I: Facing the Future 8:00 AM PT | Welcome 8:10 AM PT | Best Practices in Facial Assessment 8:30 AM PT | Fillers: Selection, Placement, and Technique 8:50 AM PT | Updates and Optimal Techniques for Neurotoxins 9:10 AM PT | Interactive Panel Q&A ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.5 contact hours are in the area of pharmacology. | |
Apr 29, 2022 9:30am - 10:30am (Pacific) | Independent CME/CE Symposium: Cellulite Treatment: The Evolving Landscape for Patient-Centric Care Learn about new tips, techniques, and therapies for managing cellulite. This live and live streamed symposium will focus on increasing awareness on the pathophysiology of cellulite, new treatment targets, and the latest clinical data and real-world experiences with cellulite treatments. Expert faculty will present their tips and demonstration videos to equip clinicians to improve management of cellulite! Sponsored by ENDO Pharmaceuticals | |
Apr 29, 2022 10:30am - 11:00am (Arizona) | Live from Scottsdale with Dr. Patel! | |
Apr 29, 2022 11:00am - 12:09pm (Arizona) | Session VII Continued: Aesthetics I: Facing the Future 11:00 AM PT | Demonstration Workshop: Fillers and Injections 12:00 PM PT | Interactive Panel Q&A ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
SESSION VII For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.5 contact hours are in the area of pharmacology. | |
Apr 29, 2022 12:15pm - 12:30pm (Pacific) | Live from Scottsdale with Dr. Patel | |
Apr 29, 2022 12:30pm - 1:15pm (Pacific) | Mild to Moderate Atopic Dermatitis and the JAK-STAT Pathway Join Dr. King for an informative session on mild to moderate atopic dermatitis and an examination of the efficacy and safety of a potential treatment option. Presentation sponsored by Incyte This is a NON-CE/CME Presentation | |
Apr 29, 2022 1:15pm - 1:40pm (Arizona) | Live from Scottsdale with Dr. Patel! | |
Apr 29, 2022 1:30pm - 3:30pm (Pacific) | Session I: Atopic Dermatitis Updates 8:00 AM PT | Welcome | |
Apr 29, 2022 1:30pm - 3:30pm (Pacific) | Eichenfield rerecord | |
Apr 29, 2022 1:40pm - 3:30pm (Arizona) | Session VIII: Aesthetics II: Body of Evidence 1:40 PM PT | Introduction 1:45 PM PT | Nonsurgical Skin Tightening 2:05 PM PT | Body Contouring 2:25 PM PT | Prejuvenation: Topical and Preventive Measures 2:45 PM PT | Combination Treatments for Targeting Cellulite 3:15 PM PT | Interactive Panel Q&A Program supported by unrestricted independent educational grant from Endo Pharmaceuticals Inc ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology. | |
Apr 29, 2022 3:30pm - 3:45pm (Arizona) | Live from Scottsdale with Dr. Patel! | |
Apr 29, 2022 3:45pm - 5:00pm (Arizona) | Session VIII Continued: Aesthetics II: Body of Evidence 3:45 PM PT | Demonstration Workshop: Body Contouring 4:45 PM PT | Brief Q&A/Wrap-Up Program supported by unrestricted independent educational grant from Endo Pharmaceuticals Inc ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
SESSION VIII For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.75 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology. | |
Apr 29, 2022 5:00pm - 5:15pm (Arizona) | BREAK: Visit Poster Hall, Activity Lounge & Networking Forum | |
Apr 29, 2022 5:15pm - 5:35pm (Pacific) | NON CME/CE Oral Poster Presentations This is a NON-CE/CME Presentation | |
Apr 30, 2022 8:00am - 10:30am (Arizona) | Session IX: The Cutting Edge on Cutaneous Malignancies 8:00 AM PT | Welcome 8:10 AM PT | The Road Ahead: Updates in the Management of Melanoma 8:30 AM PT | Expert Perspectives on Managing Patients with Cutaneous Squamous Cell Carcinoma 8:50 AM PT | Interactive Panel Q&A 9:10 AM PT | Basal Cell Carcinoma: How to Effectively Manage Your Patients 9:30 AM PT | Merkel Cell Carcinoma 9:50 AM PT | To Mohs or Not to Mohs? That is the Question! 10:10 AM PT | Interactive Panel Q&A Supported by an independent educational grant from Regeneron Pharmaceuticals and Sanofi Genzyme ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours are in the area of pharmacology. | |
Apr 30, 2022 10:30am - 11:00am (Arizona) | Live from Scottsdale with Dr. Patel! | |
Apr 30, 2022 11:00am - 1:08pm (Arizona) | Session X: Spotlight on Skin of Color in Dermatology 11:00 AM PT | Introduction 11:05 AM PT | Highlighting Disparities in Diagnosis and Treatment of Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, and Acne in Skin of Color Patients 11:20 AM PT | The Acne and Rosacea Skin of Color Challenge 11:35 AM PT | The Guide to Psoriasis in Skin of Color 11:50 AM PT | Tips for Diagnosing and Managing AD in Patients with Skin of Color 12:05 PM PT | Skin and Haircare Concerns in Patients of Color 12:25 PM PT | Aesthetic Procedures in Patients with Skin of Color 12:45 PM PT | Interactive Panel Q&A Supported by an independent educational grant from Janssen Biotech Inc, administered by Janssen Scientific Affairs, LLC Supported by an independent educational grant from Ortho Dermatologics, a division of Bausch Health Supported by an independent educational grant from La Roche-Posay (a L'Oreal brand) Supported by an independent educational grant from Arcutis Biotherapeutics, Inc. ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology. | |
Apr 30, 2022 1:05pm - 2:15pm (Pacific) | Live from Scottsdale with Dr. Patel | |
Apr 30, 2022 2:15pm - 4:05pm (Arizona) | Session XI: The OTC Skincare Playbook 2:15 PM PT | Bathing and Moisturizer Update 2:40 PM PT | Antioxidants and Skin Barrier Function 3:00 PM PT | Integrated Skin Care 3:20 PM PT | Growth Factors and Peptides 3:40 PM PT | Shining a Light on Photoprotection 4:00 PM PT | Interactive Panel Q&A Supported by an independent educational grant from La Roche-Posay (a L'Oreal brand) ACCREDITATION INFORMATION In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
For PhysiciansMedscape, LLC designates this live activity for a maximum of 2.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For NursesAwarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology. For PharmacistsMedscape designates this continuing education activity for 2.0 contact hour(s) (0.200 CEUs) (Universal Activity Number: JA0007105-0000-22-043-L01-P). | |
May. 23, 2022 - 10:00 am to Jul. 22, 2022 - 10:00 am (Pacific) | Session I Enduring: Atopic Dermatitis Updates | |
May. 23, 2022 - 10:00 am to Jul. 22, 2022 - 10:00 am (Pacific) | Session II Enduring: Pediatric Pearls for Practice | |
May. 23, 2022 - 10:00 am to Jul. 22, 2022 - 10:00 am (Pacific) | Session III Enduring: The Psoriasis Forum | |
May. 23, 2022 - 10:00 am to Jul. 22, 2022 - 10:00 am (Pacific) | Session IV: Medical Dermatology Potpourri I | |
May. 23, 2022 - 11:30 am to Jul. 22, 2022 - 11:30 am (Pacific) | Session X Enduring: Spotlight on Skin of Color in Dermatology | |
May. 23, 2022 - 11:30 am to Jul. 22, 2022 - 11:30 am (Pacific) | Session VII Enduring: Aesthetics I: Facing the Future | |
May. 23, 2022 - 11:30 am to Jul. 22, 2022 - 11:30 am (Pacific) | Session VIII Enduring: Aesthetics II: Body of Evidence | |
May. 23, 2022 - 11:30 am to Jul. 22, 2022 - 11:30 am (Pacific) | Session IX Enduring: The Cutting Edge on Cutaneous Malignancies | |
May. 23, 2022 - 11:30 am to Jul. 22, 2022 - 11:30 am (Pacific) | Session XI Enduring: The OTC Skincare Playbook |